Patent · US Active

Substituted pyrazole and triazole compounds as KSP inhibitors

US7902240B2 · kind B2 · utility

2Cited by

9References

53Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Yi Xia · South San Francisco, US
Kris Mendenhall · Concord, US
Paul A. Barsanti · Emeryville, US
Annette Walter · Mill Valley, US
David Duhl · Newington, US
Paul A. Renhowe · Danville, US

Key dates

Filing date	Nov 8, 2007
Grant date	Mar 8, 2011
Priority date	—
Expiry date	Apr 5, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.